SCHEMBL14042574

SCHEMBL14042574

Fc1ccccc1CC(NC1=NCCN1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ APOBEC3A P31941 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ APOBEC3G Q9HC16 1/20 0.46
▸ NISCH Q9Y2I1 5/20 0.43
▸ MAOA P21397 3/20 0.41
▸ MAOB P27338 3/20 0.41
▸ ADRA2A P08913 5/20 0.40
▸ ADRA2B P18089 4/20 0.40
▸ ADRA2C P18825 4/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PTGIR P43119 1/20 0.36
▸ ADRA1A P35348 2/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14042632 0.91 LMNA (0.44) LMNAGAAAPOBEC3ACTDSP1APOBEC3G
SCHEMBL14042629 0.85 NISCH (0.46) LMNANISCHMAOAMAOBADRA2A
SCHEMBL4788507 0.84 SLC6A2 (0.46) LMNAGAAAPOBEC3ACTDSP1APOBEC3G
SCHEMBL14042624 0.83 NISCH (0.45) LMNAGAAAPOBEC3ACTDSP1APOBEC3G
SCHEMBL14042628 0.82 NISCH (0.50) LMNANISCHMAOAMAOBADRA2A
SCHEMBL949042 0.82 KDM4E (0.52) LMNANISCHMAOAMAOBADRA2A
SCHEMBL14042630 0.81 CYP2D6 (0.46) NISCHMAOAMAOBADRA2AADRA2B
Iodide SCHEMBL951481 0.81 KDM4E (0.51) LMNANISCHMAOAMAOBADRA2A
SCHEMBL14042021 0.81 NISCH (0.43) LMNANISCHMAOAMAOBADRA2A
SCHEMBL4788583 0.79 NISCH (0.43) LMNANISCHMAOAMAOBADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 — — WO disclosed
Send feedback